Bixiye
QP66-24 Reminder: Patient Complaint Policy and Process Requirements
Taariikhda barnaamijka Dhaqangalayso Agosto 28, 2024
Natiijooyinka Raadinta
Soo bandhiga 871 - 880 ee natiijooyinka 4226
Bixiye
QP62-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2024
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2024
Bixiye
QP64-24 MHCP Pharmacy Benefit Exclusion for Rytelo™
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2024
Bixiye
QP63-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2024
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2024
Bixiye
P49-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Radiation Oncology Clinical Guideline Updates
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
P50-24 New Medical, Medical Drug and Behavioral Health Policy Management Updates, Effective October 7, 2024
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
P52-24 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
P53-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
2024 August Bulletins
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
P51-24 Inpatient Admission, Concurrent Review, and Discharge Submission Process Change for Commercial & Medicare Advantage Members
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024